Is anyone else getting side effects from exemestane? It reads like a known thing in the literature and is oddly absent from the popular write-ups.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
What the aromatase inhibitor class does pharmacologically does not require the subjective effect to be large to be real.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Would like a narrow answer rather than an enthusiastic one.
Read methods.
A plausible mechanism is not an outcome, and this class is the textbook example. How long have you been on exemestane?
Read methods.
What is the first thing you would read if you were starting from zero? Side effects was my main issue with exemestane too.
What is the first thing you would read if you were starting from zero?
Read methods.
Baseline first. Without a baseline the after picture is decoration.
Same here.
Not on exemestane but the pattern is familiar.
Cold storage, light protection, date on the vial. Boring, removes half the variables.